Aries Wealth Management’s Axsome Therapeutics AXSM Stock Holding History

Aries Wealth Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$676K	Hold	4,000	–	–	0.15%	121
2025 Q4	$731K	Hold	4,000	–	–	0.16%	117
2025 Q3	$486K	Hold	4,000	–	–	0.11%	145
2025 Q2	$418K	Hold	4,000	–	–	0.11%	156
2025 Q1	$467K	Hold	4,000	–	–	0.13%	144
2024 Q4	$338K	Hold	4,000	–	–	0.09%	170
2024 Q3	$359K	Hold	4,000	–	–	0.1%	167
2024 Q2	$322K	Hold	4,000	–	–	0.1%	155
2024 Q1	$319K	Hold	4,000	–	–	0.1%	159
2023 Q4	$318K	Hold	4,000	–	–	0.11%	147
2023 Q3	$268K	Hold	4,000	–	–	0.1%	162
2023 Q2	$287K	Hold	4,000	–	–	0.11%	154
2023 Q1	$247K	Hold	4,000	–	–	0.1%	166
2022 Q4	$309K	Buy	+4,000	New	+$239K	0.13%	144

Other funds holding AXSM

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return